Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07369986 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Immunotherapy for Surgery Avoidance in Vulnerable dMMR Endometrial Cancer

Study acronym: IMMUNE-SAVE
StatusNot Yet Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study First Submitted
Efficacy evaluate of iparomlimab and tuvonralimab (a PD-1/CTLA-4 bispecific antibody) in patients with surgically resectable dMMR endometrial cancer.
Trial Details
NCT Number NCT07369986
Lead Sponsor Women's Hospital School Of Medicine Zhejiang University
Conditions
(from sponsor)		 Endometrial Cancer, Immunotherapy, Mismatch Repair Deficiency
Related terms Endometrial Neoplasms, Turcot syndrome
Enrollment 30 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov